Photo by nci from unsplash
e18719Background: QoL assessment is relevant to evaluate benefit/risk ratio of cancer therapies and it is formally included in ASCO and ESMO scales of treatment value. However, its use as an… Click to show full abstract
e18719Background: QoL assessment is relevant to evaluate benefit/risk ratio of cancer therapies and it is formally included in ASCO and ESMO scales of treatment value. However, its use as an endpoi...
Keywords:
assessment reporting;
health related;
reporting health;
related quality;
biases assessment;
oncology
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!